PubMed:32338224 / 2394-2586 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-OGER-BB

    {"project":"LitCovid-OGER-BB","denotations":[{"id":"T100","span":{"begin":59,"end":67},"obj":"SP_7"},{"id":"T101","span":{"begin":77,"end":82},"obj":"SP_6"},{"id":"T102","span":{"begin":77,"end":82},"obj":"NCBITaxon:9606"},{"id":"T103","span":{"begin":77,"end":87},"obj":"PG_10"},{"id":"T104","span":{"begin":83,"end":87},"obj":"PR:000003622"},{"id":"T105","span":{"begin":118,"end":123},"obj":"SP_6"},{"id":"T106","span":{"begin":118,"end":123},"obj":"NCBITaxon:9606"},{"id":"T107","span":{"begin":124,"end":132},"obj":"SP_10"},{"id":"T108","span":{"begin":170,"end":175},"obj":"SP_6"},{"id":"T109","span":{"begin":170,"end":175},"obj":"NCBITaxon:9606"},{"id":"T110","span":{"begin":176,"end":184},"obj":"SP_10"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"According, to Wan and associates structural analysis [14], COVID-19 binds to human ACE2 with a lesser efficiency than human SARS-CoV (2002) but with higher affinity than human SARS-CoV (2003)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":59,"end":67},"obj":"Disease"},{"id":"T9","span":{"begin":124,"end":132},"obj":"Disease"},{"id":"T10","span":{"begin":176,"end":184},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"According, to Wan and associates structural analysis [14], COVID-19 binds to human ACE2 with a lesser efficiency than human SARS-CoV (2002) but with higher affinity than human SARS-CoV (2003)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T48","span":{"begin":77,"end":82},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T49","span":{"begin":93,"end":94},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T50","span":{"begin":118,"end":123},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T51","span":{"begin":170,"end":175},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"According, to Wan and associates structural analysis [14], COVID-19 binds to human ACE2 with a lesser efficiency than human SARS-CoV (2002) but with higher affinity than human SARS-CoV (2003)."}

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T15","span":{"begin":0,"end":192},"obj":"DRI_Background"}],"text":"According, to Wan and associates structural analysis [14], COVID-19 binds to human ACE2 with a lesser efficiency than human SARS-CoV (2002) but with higher affinity than human SARS-CoV (2003)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"According, to Wan and associates structural analysis [14], COVID-19 binds to human ACE2 with a lesser efficiency than human SARS-CoV (2002) but with higher affinity than human SARS-CoV (2003)."}